Clinical Trial Update: DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial (DOVIPA) evaluating dostarlimab and Vitamin D3 with mFOLFIRINOX for pancreatic cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Cholecalciferol (Vitamin D3) (cholecalciferol)
• JEMPERLI (DOSTARLIMAB)

Snippet

Sponsor: Hopital Foch | Conditions: Pancreas Neoplasms | Phase 2 | Status: RECRUITING